Ongoing studies into Semaglutide are demonstrating promising findings regarding fat reduction. Initially developed for managing diabetes , this GLP-1 receptor agonist has proven considerable efficacy https://wholesalepeptides.uk/retatrutide-vs-tirzepatide-the-next-evolution-in-metabolic-enhancement/